Fig. 3From: Metabolomic alterations associated with Behçet’s diseaseLevels of phosphatidylcholines (PCs) and polyunsaturated fatty acids (PUFAs) are affected by treatments in a different way. Comparison of the level of three PCs (a) and two PUFAs (b) in healthy controls (HC), pretreatment Behçet’s disease (BD) (Pre-) patients, and post-treatment BD (Post-) patients. The significance of metabolite levels was determined using a two-tailed student t test. *p < 0.05, ***p < 0.001. ns not significantBack to article page